Takuko Sawada

Since her appointment as a Director of the Company in 2015, Takuko Sawada has been responsible for business execution of the Corporate Strategy Division as Senior Vice President of the Corporate Strategy Division and as a Senior Executive Officer. She has also moved Medium-Term Management Plan Shionogi Growth Strategy 2020 (SGS2020) forward, and played a central role in formulating the update of SGS2020 in October 2016. Starting in FY2018, she supervises the Integrated disease care Division, Corporate strategy Division, Pharmaceutical Commercial Division and other operations in her capacity as Vice President of the Company. We therefore elected her as a Director.